NIH researchers highlight progress, path forward for developing TB vaccines
Since that time, TB researchers have assembled a significant pipeline of vaccine candidates and assessed them in clinical trials. However, to transform the field and help make licensure of new vaccines a reality, the editorial co-authors stress, scientists must investigate remaining fundamental questions, including the following: Why does infection with the TB bacterium cause active disease in some people but not others? Why does the current licensed TB vaccine, Bacille Calmette-Guérin, protect children more effectively than adults? What ...
Read the release